| 1 |
30588093 | An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer. | 2018 |
2 |
| 2 |
25808435 | An individual reference limit for 'early' diagnosis of metastatic breast cancer during postoperative follow-up. | 2015 |
2 |
| 3 |
22974092 | Evaluation of predictive markers for patients with advanced colorectal cancer. | 2012 Sep |
1 |
| 4 |
18241981 | Immunotherapy prolongs the serum CEA-TPA-CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: a retrospective longitudinal study. | 2008 May 8 |
5 |
| 5 |
17116247 | Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. | 2006 Nov 20 |
8 |
| 6 |
8119777 | Characterization of a species of non-specific cross-reacting antigen (NCA) expressed by human monocytic cell lines: structure and expression during cell differentiation. | 1994 Mar 15 |
1 |
| 7 |
1854615 | Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. | 1991 Jul |
1 |
| 8 |
2725935 | [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage]. | 1989 Apr |
1 |
| 9 |
2444456 | Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents. | 1987 Oct 15 |
2 |
| 10 |
3820841 | [Enhanced binding of 131I-labeled monoclonal anti-CEA antibody to a CEA producing lung carcinoma cell line (QG56) after phorbol ester (TPA) treatment]. | 1986 Oct |
2 |
| 11 |
4080962 | [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types]. | 1985 Jun |
1 |